SCHEMBL24309527

SCHEMBL24309527

CCc1c(Cl)nc(NSc2cnn(C)c2)nc1Oc1cccc(N2CCN(C)CC2)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 7/20 0.39
▸ DRD3 P35462 5/20 0.39
▸ HTR1A P08908 4/20 0.39
▸ DRD4 P21917 3/20 0.39
▸ HTR2A P28223 3/20 0.39
▸ HTR2C P28335 2/20 0.39
▸ BRD4 O60885 2/20 0.33
▸ BRPF1 P55201 1/20 0.33
▸ BRD9 Q9H8M2 1/20 0.33
▸ MAP3K7 O43318 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ PTK2 Q05397 1/20 0.31
▸ HTR6 P50406 3/20 0.31
▸ HTR7 P34969 1/20 0.31
▸ EGFR P00533 3/20 0.31
▸ NUAK1 O60285 1/20 0.31
▸ NUAK2 Q9H093 1/20 0.31
▸ CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310065 0.90 DRD2 (0.37) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309948 0.90 DRD2 (0.35) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310089 0.88 DRD2 (0.35) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310049 0.87 PAK1 (0.36) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310413 0.86 CTSC (0.35) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309536 0.86 BRPF1 (0.34) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309479 0.86 HTR1A (0.33) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310106 0.85 DRD2 (0.34) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309483 0.82 HTR1A (0.41) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL29566556 0.82 HTR1A (0.41) DRD2DRD3HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback